The current work was partially supported by the National Basic Research Program of China(973 Program,no.2011CB505105);We thank Guoyan Yang from National Institute of Complementary Medicine,University of Western Medicine for her suggestions in data synthesis.
Objective:To systematically evaluate the effectiveness and safety of Chinese herbal medicine (CHM) plus nucleotide analogues (NAs) for treating compensated HBV-related cirrhosis,the early stage of cirrhosis.Methods:Pu...
Supported by Grants(in part)from the Major Projects Incubator Program of National Key Basic Research Program of China,No.2012CB526700;National Natural Science Foundation of China,No.81370511;Natural Science Foundation of Guangdong Province,No.S2011020002348;Fundamental Research Funds for the Central Universities,No.13ykjc01 and No.82000-3281901
AIM: To investigate the etiology and complications of liver cirrhosis (LC) in Southern China.
Aberrant glycan structure of serum glycoproteins creates unique patterns in different stages of hepatocellular carcinoma (HCC), which provides potential glycan biomarkers for early diagnosis of HCC. In this study, t...
Supported by The Ministry of Science and Technology of China,No. 2009ZX09312-025 and No. 2008ZX10002-018
AIM:To quantitatively investigate the effect of p16 hypermethylation on hepatocellular carcinoma (HCC) and hepatocirrhosis using a meta-analysis of available casecontrol studies.METHODS:Previous studies have primarily...
Supported by the Major State Basic Research Development Program of China(973 Program),No.2001CB510001
AIM: To find new serum biomarkers for liver cirrhosis (LC) in chronic carriers of hepatitis B virus (HBV).METHODS: Surface enhanced laser desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry was used to ...